- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 03-09-2026: Press Release
03-09-2026 | 08:13 pm
03-09-2026 | 08:13 pm
Cipla's US subsidiary partners with Qilu for exclusive licensing & supply of a Keytruda biosimilar (QL2107) in the US market. This strategic move aims to expand Cipla's oncology portfolio and improve access to affordable biologics.
No comments yet. Be the first to comment!